Stopfer LE, Gajadhar AS, Patel B, Gallien S, Frederick DT, Boland GM, Sullivan RJ, White FM.  2021.  Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants.. Proc Natl Acad Sci U S A. 118(37)

Basu SS, Agar NYR.  2021.  Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics.. Clin Lab Med. 41(2):309-324.

Stopfer LE, Flower CT, Gajadhar AS, Patel B, Gallien S, Lopez-Ferrer D, White FM.  2021.  High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors.. Cancer Res. 81(9):2495-2509.

Kohale IN, Burgenske DM, Mladek AC, Bakken KK, Kuang J, Boughey JC, Wang L, Carter JM, Haura EB, Goetz MP et al..  2021.  Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient-specific signaling networks.. Cancer Res.

Stopfer LE, Conage-Pough JE, White FM.  2021.  Quantitative consequences of protein carriers in immunopeptidomics and tyrosine phosphorylation MS analyses.. Mol Cell Proteomics. :100104.

Shaaya M, Fauser J, Zhurikhina A, Conage-Pough JE, Huyot V, Brennan M, Flower CT, Matsche J, Khan S, Natarajan V et al..  2020.  Light-regulated allosteric switch enables temporal and subcellular control of enzyme activity.. Elife. 9

Randall EC, Lopez BGC, Peng S, Regan MS, Abdelmoula WM, Basu SS, Santagata S, Yoon H, Haigis MC, Agar JN et al..  2020.  Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma.. Cancer Res. 80(6):1258-1267.

Morshed N, Ralvenius WT, Nott A, L Watson A, Rodriguez FH, Akay LA, Joughin BA, Pao P-C, Penney J, LaRocque L et al..  2020.  Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.. Mol Syst Biol. 16(12):e9819.

Freedman RA, Gelman RS, Agar NYR, Santagata S, Randall EC, Lopez BGimenez-Ca, Connolly RM, Dunn IF, Van Poznak CH, Anders CK et al..  2020.  Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.. Clin Breast Cancer. 20(2):145-151.e2.

Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth DA, Jarrett AM, Lima EABF, J Oden T et al..  2019.  The 2019 mathematical oncology roadmap.. Phys Biol. 16(4):041005.

Abdelmoula WM, Regan MS, Lopez BGC, Randall EC, Lawler S, Mladek AC, Nowicki MO, Marin BM, Agar JN, Swanson KR et al..  2019.  Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.. Anal Chem. 91(9):6206-6216.

Gampa G, Kim M, Mohammad AS, Parrish KE, Mladek AC, Sarkaria JN, Elmquist WF.  2019.  Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.. J Pharmacol Exp Ther. 368(3):446-461.

Kim M, Laramy JK, Mohammad AS, Talele S, Fisher J, Sarkaria JN, Elmquist WF.  2019.  Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and -Deficient Mice.. Drug Metab Dispos. 47(4):393-404.

Massey SC, Hawkins-Daarud A, Gallaher J, Anderson ARA, Canoll P, Swanson KR.  2019.  Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue.. Bull Math Biol.

Basu SS, McMinn MH, Lopez BGimenez-Ca, Regan MS, Randall EC, Clark AR, Cox CR, Agar NYR.  2019.  Metal Oxide Laser Ionization Mass Spectrometry Imaging (MOLI MSI) Using Cerium(IV) Oxide.. Anal Chem. 91(10):6800-6807.

Koohi-Moghadam M, Borad M, Tran N, Swanson K, Boardman L, Sun H, Wang J.  2019.  MetaMarker: a de novo pipeline for discovering novel metagenomic biomarkers.. Bioinformatics.

White FM, Gatenby RA, Fischbach C.  2019.  The Physics of Cancer.. Cancer Res. 79(9):2107-2110.

Hawkins-Daarud A, Johnston SK, Swanson KR.  2019.  Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.. JCO Clin Cancer Inform. 3:1-8.

Basu SS, Regan MS, Randall EC, Abdelmoula WM, Clark AR, Lopez BGimenez-Ca, Cornett DS, Haase A, Santagata S, Agar NYR.  2019.  Rapid MALDI mass spectrometry imaging for surgical pathology.. NPJ Precis Oncol. 3:17.

Jaeger AM, Stopfer L, Lee S, Gaglia G, Sandel D, Santagata S, Lin NU, Trepel JB, White F, Jacks T et al..  2019.  Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation.. Clin Cancer Res. 25(21):6392-6405.

Schwill M, Tamaskovic R, Gajadhar AS, Kast F, White FM, Plückthun A.  2019.  Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancer.. Sci Signal. 12(565)

Kim M, Kizilbash SH, Laramy JK, Gampa G, Parrish KE, Sarkaria JN, Elmquist WF.  2018.  Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.. Pharm Res. 35(9):177.

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK et al..  2018.  Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol. 20(2):184-191.

Bergmann S, Lawler SE, Qu Y, Fadzen CM, Wolfe JM, Regan MS, Pentelute BL, Agar NYR, Cho C-F.  2018.  Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics.. Nat Protoc. 13(12):2827-2843.

Gampa G, Kim M, Cook-Rostie N, Laramy JK, Sarkaria JN, Paradiso L, DePalatis L, Elmquist WF.  2018.  Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases.. Drug Metab Dispos. 46(5):658-666.